Soft tissue sarcoma: Clinical practice guidelines in oncology Journal Article
| Authors: | Demetri, G. D.; Baker, L. H.; Beech, D.; Benjamin, R.; Casper, E. S.; Conrad, E. U. 3rd; DeLaney, T. F.; Ettinger, D. S.; Heslin, M. J.; Hutchinson, R. J.; Kiel, K.; Kraybill, W. G.; Letson, G. D.; Neff, J.; O'Donnell, R. J.; Paz, I. B.; Pollock, R. E.; Randall, R. L.; Schupak, K. D.; Tyler, D. S.; von Mehren, M.; Wayne, J. |
| Article Title: | Soft tissue sarcoma: Clinical practice guidelines in oncology |
| Abstract: | Sarcomas constitute a complex and diverse family of rare, clinicopathologically distinct malignant neoplasms of mesenchymal cell origin. The annual incidence of soft tissue sarcomas in the United States for 2004 is estimated to be about 8,680 cases, with an overall mortality rate of approximately 3,660 cases per year, including adults and children. The expertise of the NCCN institutions allows the panel to use their extensive experience in defining these consensus practice guidelines for the management of patients with sarcomas. These guidelines address sarcoma management from the perspective of four disease subtypes: soft tissue extremity sarcomas, retroperitoneal (including nongastrointestinal visceral) sarcomas, gastrointestinal stromal tumors and other intra-abdominal sarcomas, and the unique mesenchymal neoplasm known as desmoid tumor (or desmoid aggressive fibromatosis). © Journal of the National Comprehensive Cancer Network. |
| Keywords: | cancer chemotherapy; cancer surgery; clinical trial; review; cancer recurrence; doxorubicin; interferon; sunitinib; chemoembolization; antineoplastic agents; clinical trials as topic; gemcitabine; cancer adjuvant therapy; cancer radiotherapy; combined modality therapy; chemotherapy; methotrexate; topotecan; cancer staging; follow up; gastrointestinal stromal tumor; imatinib; gastrointestinal stromal tumors; dacarbazine; etoposide; radiotherapy; nccn clinical practice guidelines; cyclophosphamide; practice guideline; tumor biopsy; angiosarcoma; ifosfamide; vinblastine; docetaxel; irinotecan; sarcoma; celecoxib; cardiovascular disease; nonsteroid antiinflammatory agent; sulindac; daunorubicin; soft tissue sarcoma; tamoxifen; surgery; radiation therapy; taxane derivative; mesna; trabectedin; rhabdomyosarcoma; navelbine; retinoic acid; soft tissue neoplasms; toremifene; desmoid tumor; cryotherapy; soft tissue extremity sarcoma; retroperitoneal sarcomas |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 3 |
| Issue: | 2 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2005-03-01 |
| Start Page: | 158 |
| End Page: | 194 |
| Language: | English |
| PUBMED: | 19817028 |
| PROVIDER: | scopus |
| PMCID: | PMC5788173 |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 4" - "Export Date: 24 October 2012" - "Source: Scopus" |
Citation Impact
Related MSK Work